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INTRODUCTION:  Solid  pseudopapillary  tumor  (SPT)  of  pancreas  is  an  unusual  low-grade  malignant  epithe-
lial  tumor  that  usually  occurs  in young  women  and  can be  treated  with  surgical  resection.  Renal  cell





PRESENTATION  OF  CASE:  In  this  article  we present  a  case  of  RCC  with  concomitant  SPT  of  the  pancreas
who  was treated  successfully  with  a radical  nephrectomy  and  distal  pancreatectomy.
DISCUSSION: RCC  with  concomitant  SPT  may  associated  in  -catenin  gene  mutation.  But no  prior  reports
have  described  RCC  with  concomitant  SPT  of  the pancreas  in  the  same  patient.
CONCLUSION: To  the  best  of  our  knowledge,  this  is  the  ﬁrst  report  of RCC  with  concomitant  SPT  of  the
pancreas  in  the same  patient.
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. Introduction
Renal cell carcinoma (RCC) represents 2–3% of all adult can-
ers, is the most common solid lesion of the kidney, with typical
resentation in the sixth and seventh decades of life.1,2
Solid pseudopapillary tumor (SPT) of pancreas is rare neoplasm,
omprising approximately 1–2% of all exocrine pancreatic tumors
ith low malignant potential.3,4 There is a strong female prepon-
erance, and most cases present in the third and fourth decade of
ife. SPT typically presents with non-speciﬁc symptoms of abdomi-
al pain and/or a palpable abdominal mass. The usual treatment
s surgical resection; after resection, the prognosis is generally
avorable.5 In this article we present a case of RCC with concomitant
PT of the pancreas in a 53-year old Turkish women who under-
ent a successful radical nephrectomy with distal pancreatectomy.
ccording to our knowledge this is the ﬁrst case which have RCC
ith concomitant SPT of the pancreas.
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2. Presentation of case
A  53-year old Turkish women with nonspeciﬁc abdominal
pain was  admitted to our hospital. She underwent an abdomi-
nal ultrasound and 4 cm × 4.5 cm in size solid mass in the right
kidney was  detected. A dynamic computed tomography was  per-
formed subsequently and showed enhancing solid mass in the
right kidney which in size 4.3 cm × 4 cm and solid-cystic mass
in the tail of the pancreas which slight heterogeneous enhanc-
ing in portal venous phase and surrounding the splenic vessels
(Figs. 1 and 2). The patient underwent right laparascopic radi-
cal nephrectomy and distal pancreatectomy. After transperitoneal
laparascopic nephrectomy the position of the patient was  changed
to supine position. The surgical team started the operation with
four transperitoneally located abdominal ports, but near the end of
the operation due to an abundant bleeding which was  uncontrolled
laparoscopically the operation was  shifted to open procedure and
distal pancreatectomy was executed with open surgical proce-
dure. Additionally, during the operation it was  detected that the
splenic vessels were surrounded by pancreatic mass. Therefore
splenectomy was performed. Pathology of the renal mass was
Fuhrman nuclear grade 1 renal cell carcinoma limited to the
kidney. On gross pathology, the pancreatic tumor was 4 cm in
maximum diameter that invaded splenic hilus and including solid
and cystic components (Fig. 3). Microscopically, the solid areas
consisted of uniform polyedral eosinophilic cells arranged around
Open access under CC BY-NC-SA license.delicate ﬁbrovascular stalks. Rare mitotic ﬁgures and localized
necrotic areas were also determined. Immunohistochemical anal-
ysis was  positive for vimentin, CD56, beta-catenin, and cyclin-D1
(Fig. 4).
s Ltd. Open access under CC BY-NC-SA license.
CASE  REPORT  –  OPEN  ACCESS
D. Atilgan et al. / International Journal of Surgery Case Reports 4 (2013) 828– 830 829








aFig. 2. CT image of solid-cystic mass in the tail of the pancreas (black arrow).
Postoperative course was unremarkable and patient was  dis-
harged on post-operative day 7 in good condition.
. Discussion
SPT of the pancreas constitutes a distinctive and relatively
ncommon clinicopathologic entity. It was ﬁrst described by
rantz in 1959 and was deﬁned by the World Health Organi-
ation (WHO) in 1996 as “solid pseudopapillary tumors” of the
ancreas. Increased use of advanced radiological techniques has
ig. 3. Macroscpic view of a solid-cystic tumor in the tail of the pancreas (white
rrow).Fig. 4. microscopic view of beta-catenin positivity in SPT cells (DAB, 20×).
led to increased prevalence of SPT in recent years.3,4,6 The vast
majority of cases are within the range 20–40 years old and less
than 10% of the tumors occur in patients older than 40 years.7
Our patient is 53-year old as old as SPT of the pancreas is rarely
seen in. Clinically, SPT may  present as an abdominal mass with
discomfort or pain, or almost 30% of the SPT may  be an inciden-
tal ﬁnding in work up for unrelated conditions.8 The symptomatic
tumors are generally large and approximately 64% arise in the body
and tail of the pancreas.9 Radiologic imaging is an essential part
of the diagnosis of pancreatic SPT. In CT scan SPT demonstrate
no enhancement of the cystic portions but slight enhancement
of the solid portions in the arterial phase and marked enhance-
ment in the portal venous phase.10 The tumor may  involve any
portion of the pancreas but the head and tail are most common.5,11
Although the malignant potential of SPT is low, up to 15% of SPT
patients develop metastasis. The most common sites of metasta-
sis are the liver, regional lymph nodes, mesentery, omentum, and
peritoneum.12 Angioinvasion, perineural invasion and deep inva-
sion of pancreatic tissue characterize malignancy.13 In our case
we have seen that splenic artery and vein was invaded by SPT of
pancreas.
SPT is characterized by the presence of activating -catenin
gene mutations that interfere with phosphorylation of the protein
product.14 Though -catenin-activating point mutations are rare
in RCC,15 elevation of -catenin levels by induced overexpression
induces renal tumors in mice.16 RCC with concomitant SPT may
associated in -catenin gene mutation. But no prior reports have
described RCC with concomitant SPT of the pancreas in the same
patient.
4. Conclusion
To the best of our knowledge, this is the ﬁrst report of RCC with
concomitant SPT of the pancreas in the same patient. Distal pan-
createctomy may  be curative treatment for SPTs which located in
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